Market Overview:
The global elastomers for pharmaceuticals market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for elastomers from the pharmaceutical industry, owing to their properties such as biocompatibility, non-toxicity, and resistance to degradation. In addition, the growing trend of using elastomeric materials in medical devices is also contributing significantly towards the growth of this market. Based on type, thermoset elastomers are expected to account for a major share of the global elastomers for pharmaceuticals market during the forecast period. This can be attributed mainly to their high durability and chemical resistance properties which make them suitable for use in various medical applications such as stoppers and syringes.
Product Definition:
Elastomers are substances that can be stretched and then return to their original shape. They are often used in pharmaceuticals to form pills or capsules. The elastomer helps the pill hold its shape and also makes it easier to swallow.
Thermoset Elastomers:
Thermoset elastomers are cross-linked polymers that do not melt easily. They have a high resistance to heat and chemicals, and also have a good elasticity modulus. Thermoset elastomers are used in the production of sealants, coatings, adhesives & sealant removers for drug delivery systems as well as in the manufacturing of implants.
Thermoplastic Elastomers:
Thermoplastic elastomers (TPEs) are a new class of material that has been gaining importance in the past few years. They have unique properties such as high tear resistance, low-temperature flexibility, and excellent solvent resistance. TPEs also display good UV stability and wearability which makes them suitable for use in contact lenses as well as other applications where these properties are required.
Application Insights:
Stoppers application segment led the global elastomers for pharmaceuticals market and accounted for more than 35.0% share of the overall revenue in 2017. The growth in this segment can be attributed to high demand from various industries, such as food & beverage and consumer goods, which are using stoppered bottles for packaging products.
The syringes application segment is expected to witness significant growth over the forecast period owing to increasing use of polymers, such as PBT and ABS resins, by manufacturers of medical devices & equipment. These materials offer advantages including biocompatibility along with good mechanical properties required for manufacturing syringes that are used across a wide range of temperatures ranging from below freezing point down to room temperature.
Needle shields also form an integral part of any drug delivery system designed by a manufacturer; these systems require injection-molded plastic components that have good impact strength.
Regional Analysis:
North America accounted for the largest share of over 35% in 2017. The region is expected to maintain its dominance during the forecast period owing to high demand from various end-use industries, such as medical devices and pharmaceuticals. In addition, increasing R&D activities by major companies are also contributing towards market growth in this region.
Asia Pacific is anticipated to be one of the fastest-growing regions with a CAGR of XX% from 2018 to 2030 due to rapid economic development coupled with rising healthcare spending by countries like China and India which has resulted into increased product penetration across these economies over the past few years.
Moreover, government initiatives encouraging domestic manufacturing activities are expected boost regional production levels which will further propel demand for elastomers across this region’s economy over coming years .
Growth Factors:
- Increasing demand for elastomers in the pharmaceutical industry due to their properties such as biocompatibility, non-toxicity, and chemical resistance.
- Rising demand from emerging markets due to the growth of the pharmaceutical sector in these regions.
- Growing use of elastomers in drug delivery systems and medical devices owing to their properties such as flexibility and elasticity.
- Technological advancements that are resulting in the development of new types of elastomers with better properties suited for use in pharmaceutical applications.
Scope Of The Report
Report Attributes
Report Details
Report Title
Elastomers for Pharmaceuticals Market Research Report
By Type
Thermoset Elastomers, Thermoplastic Elastomers
By Application
Stoppers, Syringes, Needle Shields, Others
By Companies
Exxon Mobil Corporation, DuPont, BASF SE, Dow, Kuraray Co. Ltd, Lubrizol Corp, Bailey-Parks Urethane Inc, Covestro, Arkema Group, Hexpol Compounding, Avient Corporation, Teknor Apex Company, Austin Novel Materials Co, Huafon Group, Miracll Chemicals Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Elastomers for Pharmaceuticals Market Report Segments:
The global Elastomers for Pharmaceuticals market is segmented on the basis of:
Types
Thermoset Elastomers, Thermoplastic Elastomers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Stoppers, Syringes, Needle Shields, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Exxon Mobil Corporation
- DuPont
- BASF SE
- Dow
- Kuraray Co. Ltd
- Lubrizol Corp
- Bailey-Parks Urethane Inc
- Covestro
- Arkema Group
- Hexpol Compounding
- Avient Corporation
- Teknor Apex Company
- Austin Novel Materials Co
- Huafon Group
- Miracll Chemicals Ltd
Highlights of The Elastomers for Pharmaceuticals Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Thermoset Elastomers
- Thermoplastic Elastomers
- By Application:
- Stoppers
- Syringes
- Needle Shields
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Elastomers for Pharmaceuticals Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Elastomers are a type of polymer that is used in the pharmaceutical industry to create capsules, tablets, and other dosage forms. Elastomers are also used as coatings on pills and other medications to help them dissolve more quickly in the stomach.
Some of the major players in the elastomers for pharmaceuticals market are Exxon Mobil Corporation, DuPont, BASF SE, Dow, Kuraray Co. Ltd, Lubrizol Corp, Bailey-Parks Urethane Inc, Covestro, Arkema Group, Hexpol Compounding, Avient Corporation, Teknor Apex Company, Austin Novel Materials Co, Huafon Group, Miracll Chemicals Ltd.
The elastomers for pharmaceuticals market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Elastomers for Pharmaceuticals Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Elastomers for Pharmaceuticals Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Elastomers for Pharmaceuticals Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Elastomers for Pharmaceuticals Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Elastomers for Pharmaceuticals Market Size & Forecast, 2018-2028 4.5.1 Elastomers for Pharmaceuticals Market Size and Y-o-Y Growth 4.5.2 Elastomers for Pharmaceuticals Market Absolute $ Opportunity
Chapter 5 Global Elastomers for Pharmaceuticals Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Elastomers for Pharmaceuticals Market Size Forecast by Type
5.2.1 Thermoset Elastomers
5.2.2 Thermoplastic Elastomers
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Elastomers for Pharmaceuticals Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Elastomers for Pharmaceuticals Market Size Forecast by Applications
6.2.1 Stoppers
6.2.2 Syringes
6.2.3 Needle Shields
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Elastomers for Pharmaceuticals Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Elastomers for Pharmaceuticals Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Elastomers for Pharmaceuticals Analysis and Forecast
9.1 Introduction
9.2 North America Elastomers for Pharmaceuticals Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Elastomers for Pharmaceuticals Market Size Forecast by Type
9.6.1 Thermoset Elastomers
9.6.2 Thermoplastic Elastomers
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Elastomers for Pharmaceuticals Market Size Forecast by Applications
9.10.1 Stoppers
9.10.2 Syringes
9.10.3 Needle Shields
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Elastomers for Pharmaceuticals Analysis and Forecast
10.1 Introduction
10.2 Europe Elastomers for Pharmaceuticals Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Elastomers for Pharmaceuticals Market Size Forecast by Type
10.6.1 Thermoset Elastomers
10.6.2 Thermoplastic Elastomers
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Elastomers for Pharmaceuticals Market Size Forecast by Applications
10.10.1 Stoppers
10.10.2 Syringes
10.10.3 Needle Shields
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Elastomers for Pharmaceuticals Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Elastomers for Pharmaceuticals Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Elastomers for Pharmaceuticals Market Size Forecast by Type
11.6.1 Thermoset Elastomers
11.6.2 Thermoplastic Elastomers
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Elastomers for Pharmaceuticals Market Size Forecast by Applications
11.10.1 Stoppers
11.10.2 Syringes
11.10.3 Needle Shields
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Elastomers for Pharmaceuticals Analysis and Forecast
12.1 Introduction
12.2 Latin America Elastomers for Pharmaceuticals Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Elastomers for Pharmaceuticals Market Size Forecast by Type
12.6.1 Thermoset Elastomers
12.6.2 Thermoplastic Elastomers
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Elastomers for Pharmaceuticals Market Size Forecast by Applications
12.10.1 Stoppers
12.10.2 Syringes
12.10.3 Needle Shields
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Elastomers for Pharmaceuticals Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Elastomers for Pharmaceuticals Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Elastomers for Pharmaceuticals Market Size Forecast by Type
13.6.1 Thermoset Elastomers
13.6.2 Thermoplastic Elastomers
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Elastomers for Pharmaceuticals Market Size Forecast by Applications
13.10.1 Stoppers
13.10.2 Syringes
13.10.3 Needle Shields
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Elastomers for Pharmaceuticals Market: Competitive Dashboard
14.2 Global Elastomers for Pharmaceuticals Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Exxon Mobil Corporation
14.3.2 DuPont
14.3.3 BASF SE
14.3.4 Dow
14.3.5 Kuraray Co. Ltd
14.3.6 Lubrizol Corp
14.3.7 Bailey-Parks Urethane Inc
14.3.8 Covestro
14.3.9 Arkema Group
14.3.10 Hexpol Compounding
14.3.11 Avient Corporation
14.3.12 Teknor Apex Company
14.3.13 Austin Novel Materials Co
14.3.14 Huafon Group
14.3.15 Miracll Chemicals Ltd